Allt inom MAR
Nanexa publishes interim report for January-March 2024
NEX-22 clinical trial preparations ongoing and Novo Nordisk collaboration progressing well
Nanexa publishes year-end report and Q4 report 2023
NEX-22 clinical trial application submitted, secured funding and tactical priorities for 2024
